6 insiders reported 15 Form 4 transactions for OKYO Pharma Ltd (OKYO) over the past 18 months (most recent 2026-08-07). Recent activity: CERRONE GABRIELE M (Director) Buy 22,500 shares, CERRONE GABRIELE M (Director) Buy 25,000 shares, JACOB GARY S (CHIEF DEVELOPMENT OFFICER) Buy 3,500 shares, BRANCACCIO JOHN P (Director) Buy 5,000 shares, Patil Rajkumar V. (Chief Scientific Officer) Buy 3,363 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-07 | CERRONE GABRIELE M | Director | Buy | 22,500 | $32,625 |
| 2026-08-07 | CERRONE GABRIELE M | Director | Buy | 25,000 | $35,000 |
| 2026-08-07 | JACOB GARY S | CHIEF DEVELOPMENT OFFICER | Buy | 3,500 | $4,900 |
| 2026-08-07 | BRANCACCIO JOHN P | Director | Buy | 5,000 | $7,385 |
| 2026-08-07 | Patil Rajkumar V. | Chief Scientific Officer | Buy | 3,363 | $5,011 |
| 2026-08-07 | Dempsey Robert John | CHIEF EXECUTIVE OFFICER | Buy | 15,000 | $23,085 |
| 2026-08-07 | Mantelli Flavio | CHIEF MEDICAL OFFICER | Buy | 20,000 | $28,000 |
| 2026-07-29 | Patil Rajkumar V. | Chief Scientific Officer | Buy | 3,363 | $5,011 |
| 2026-07-23 | CERRONE GABRIELE M | Director | Buy | 22,500 | $32,625 |
| 2026-07-23 | JACOB GARY S | CHIEF DEVELOPMENT OFFICER | Buy | 3,500 | $4,900 |
| 2026-07-23 | BRANCACCIO JOHN P | Director | Buy | 5,000 | $7,385 |
| 2026-07-23 | Dempsey Robert John | CHIEF EXECUTIVE OFFICER | Buy | 15,000 | $23,085 |
| 2026-07-22 | Mantelli Flavio | CHIEF MEDICAL OFFICER | Buy | 20,000 | $28,000 |
| 2026-07-21 | CERRONE GABRIELE M | Director | Buy | 25,000 | $35,000 |
| 2026-06-10 | CERRONE GABRIELE M | Director | Buy | 300,000 | $516,000 |
Source: SEC Form 4 filings · as of 2026-08-07